Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3.

Tytuł :
Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3.
Autorzy :
Wang M; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China. Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China. Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Li Z; Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Bio-X Institutes, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
Chu H; Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China. Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Lv Q; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
Ding Q; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Xu C; Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
Guo J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
Du M; Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China. Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Chen J; Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Bio-X Institutes, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
Song Z; Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Bio-X Institutes, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
Yin C; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qin C; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Gu C; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
Zhu Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
Xia G; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Liu F; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Zhang Z; Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
Yuan L; Department of Urology, Jiangsu Province Hospital of TCM, Nanjing, China.
Fu G; Department of Urology, The Huai-An First Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Hu Z; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
Tong N; Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China.
Shen J; Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Bio-X Institutes, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
Liu K; Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Bio-X Institutes, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
Sun J; Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Sun Y; Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
Li J; Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Bio-X Institutes, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
Li X; Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Bio-X Institutes, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
Shen H; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
Xu J; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina. Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois. .
Shi Y; Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Bio-X Institutes, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China. Shandong Provincial Key Laboratory of Metabolic Disease, The Affiliated Hospital of Qingdao University, Qingdao, China. Department of Psychiatry, The First Teaching Hospital of Xinjiang Medical University, Urumqi, China. Institute of Neuropsychiatric Science and Systems Biological Medicine, Shanghai Jiao Tong University, Shanghai, China. Institute of Social Cognitive and Behavioral Sciences, Shanghai Jiao Tong University, Shanghai, China. .
Zhang Z; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China. Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China. Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China. .
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2016 Jun 01; Vol. 76 (11), pp. 3277-84. Date of Electronic Publication: 2016 Mar 29.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Język :
English
Imprint Name(s) :
Publication: Baltimore, Md. : American Association for Cancer Research
Original Publication: Chicago [etc.]
MeSH Terms :
Genome-Wide Association Study*
Biomarkers, Tumor/*genetics
Chromosomes, Human, Pair 5/*genetics
Cyclophilins/*genetics
Polymorphism, Single Nucleotide/*genetics
Urinary Bladder Neoplasms/*genetics
Aged ; Biomarkers, Tumor/metabolism ; Case-Control Studies ; Cohort Studies ; Cyclophilins/metabolism ; Female ; Follow-Up Studies ; Genetic Predisposition to Disease ; Genotype ; Humans ; Immunoenzyme Techniques ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Prognosis ; RNA, Messenger/genetics ; Real-Time Polymerase Chain Reaction ; Reverse Transcriptase Polymerase Chain Reaction ; Survival Rate ; Urinary Bladder Neoplasms/pathology
Substance Nomenclature :
0 (Biomarkers, Tumor)
0 (RNA, Messenger)
EC 5.2.1.- (Cwc27 protein, human)
EC 5.2.1.- (Cyclophilins)
Entry Date(s) :
Date Created: 20160522 Date Completed: 20170728 Latest Revision: 20171030
Update Code :
20210209
DOI :
10.1158/0008-5472.CAN-15-2564
PMID :
27206850
Czasopismo naukowe
Genome-wide association studies (GWAS) of bladder cancer have identified a number of susceptibility loci in European populations but have yet to uncover the genetic determinants underlying bladder cancer incidence among other ethnicities. Therefore, we performed the first GWAS in a Chinese cohort comprising 3,406 cases of bladder cancer and 4,645 controls. We identified a new susceptibility locus for bladder cancer at 5q12.3, located in the intron of CWC27 (rs2042329), that was significantly associated with disease risk (OR = 1.40; P = 4.61 × 10(-11)). However, rs2042329 was not associated with bladder cancer risk in patients of European descent. The rs2042329 risk allele was also related to significantly increased expression levels of CWC27 mRNA and protein in bladder cancer tissues from Chinese patients. Additional functional analyses suggested that CWC27 played an oncogenic role in bladder cancer by inducing cell proliferation and suppressing apoptosis. In conclusion, the identification of a risk-associated locus at 5q12.3 provides new insights into the inherited susceptibility to bladder cancer in Chinese populations and may help to identify high-risk individuals. Cancer Res; 76(11); 3277-84. ©2016 AACR.
(©2016 American Association for Cancer Research.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies